🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of Denosuma...
Status
Unknown
Location
Rheumatology Center of Iran
Start Date
2017-04-29
Trial ID
NCT03293108
The purpose of this study is to assess the efficacy and safety of Hyalgan a...
Status
Completed
Location
Siriraj Hospital, Faculty of Medicine, Mahidol university
Start Date
2009-02
Trial ID
NCT01267214
Treatments Being Tested
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
Phase 2/3 randomized, parallel group, 2-arm study (treatment vs. control), ...
Status
Completed
Location
Hospital Universitario Miguel Servet
Start Date
2020-05-08
Trial ID
NCT04443881
Treatments Being Tested
To study the efficacy and safety of icatibant in adult patients admitted to...
Status
Completed
Location
Hospital Universitari de Bellvitge
Start Date
2021-04-12
Trial ID
NCT04978051
The purpose of the study is to evaluate the efficacy, safety, pharmacokinet...
Status
Completed
Location
Renstar Medical Research
Start Date
2017-02-28
Trial ID
NCT02905331
Treatments Being Tested
This study is to compare the Pharmacokinetics, Pharmacodynamics, safety, an...
Status
Completed
Location
Biotrial Inc
Start Date
2022-03-09
Trial ID
NCT05323708
This trial will investigate the pharmacokinetics, safety and tolerability o...
Status
Completed
Location
1297.1.002 Boehringer Ingelheim Investigational Site
Start Date
2011-12-01
Trial ID
NCT01505491
Treatments Being Tested
EFC18418 is a multinational, randomized, double-blind, placebo-controlled, ...
Status
Active Not Recruiting
Location
University of Southern California (USC) / Keck Medicine of USC- Site Number : 8400037
Start Date
2025-02-12
Trial ID
NCT06834347
Treatments Being Tested